These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9653049)

  • 1. G protein-coupled receptors in HIV and SIV entry: new perspectives on lentivirus-host interactions and on the utility of animal models.
    Unutmaz D; KewalRamani VN; Littman DR
    Semin Immunol; 1998 Jun; 10(3):225-36. PubMed ID: 9653049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of GPR1, GPR15, and STRL33 as coreceptors by diverse human immunodeficiency virus type 1 and simian immunodeficiency virus envelope proteins.
    Edinger AL; Hoffman TL; Sharron M; Lee B; O'Dowd B; Doms RW
    Virology; 1998 Sep; 249(2):367-78. PubMed ID: 9791028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The function of simian chemokine receptors in the replication of SIV.
    Marx PA; Chen Z
    Semin Immunol; 1998 Jun; 10(3):215-23. PubMed ID: 9653048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary SIVsm isolates use the CCR5 coreceptor from sooty mangabeys naturally infected in west Africa: a comparison of coreceptor usage of primary SIVsm, HIV-2, and SIVmac.
    Chen Z; Gettie A; Ho DD; Marx PA
    Virology; 1998 Jun; 246(1):113-24. PubMed ID: 9656999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-receptor usage of BOB/GPR15 in addition to CCR5 has no significant effect on replication of simian immunodeficiency virus in vivo.
    Pöhlmann S; Stolte N; Münch J; Ten Haaft P; Heeney JL; Stahl-Hennig C; Kirchhoff F
    J Infect Dis; 1999 Nov; 180(5):1494-502. PubMed ID: 10515808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression cloning of new receptors used by simian and human immunodeficiency viruses.
    Deng HK; Unutmaz D; KewalRamani VN; Littman DR
    Nature; 1997 Jul; 388(6639):296-300. PubMed ID: 9230441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coreceptor usage of BOB/GPR15 and Bonzo/STRL33 by primary isolates of human immunodeficiency virus type 1.
    P Hlmann S; Krumbiegel M; Kirchhoff F
    J Gen Virol; 1999 May; 80 ( Pt 5)():1241-1251. PubMed ID: 10355771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemokine coreceptor usage by diverse primary isolates of human immunodeficiency virus type 1.
    Zhang L; He T; Huang Y; Chen Z; Guo Y; Wu S; Kunstman KJ; Brown RC; Phair JP; Neumann AU; Ho DD; Wolinsky SM
    J Virol; 1998 Nov; 72(11):9307-12. PubMed ID: 9765480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-function studies of the HIV-1 coreceptors.
    Berson JF; Doms RW
    Semin Immunol; 1998 Jun; 10(3):237-48. PubMed ID: 9653050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonproductive human immunodeficiency virus type 1 infection of human fetal astrocytes: independence from CD4 and major chemokine receptors.
    Sabri F; Tresoldi E; Di Stefano M; Polo S; Monaco MC; Verani A; Fiore JR; Lusso P; Major E; Chiodi F; Scarlatti G
    Virology; 1999 Nov; 264(2):370-84. PubMed ID: 10562499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4-Dependent and CD4-independent utilization of coreceptors by human immunodeficiency viruses type 2 and simian immunodeficiency viruses.
    Liu HY; Soda Y; Shimizu N; Haraguchi Y; Jinno A; Takeuchi Y; Hoshino H
    Virology; 2000 Dec; 278(1):276-88. PubMed ID: 11112502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD4+ CCR5+ T-cell dynamics during simian immunodeficiency virus infection of Chinese rhesus macaques.
    Monceaux V; Viollet L; Petit F; Cumont MC; Kaufmann GR; Aubertin AM; Hurtrel B; Silvestri G; Estaquier J
    J Virol; 2007 Dec; 81(24):13865-75. PubMed ID: 17898067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chemokine receptors and its importance in the replication cycle of human immunodeficiency virus: clinical and therapeutic implications].
    Azevedo-Pereira JM; Santos-Costa Q
    Acta Med Port; 2008; 21(5):497-504. PubMed ID: 19187693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of CCR5-mediated infection by diverse R5 and R5X4 HIV and SIV isolates using novel small molecule inhibitors of CCR5: effects of viral diversity, target cell and receptor density.
    Willey S; Peters PJ; Sullivan WM; Dorr P; Perros M; Clapham PR
    Antiviral Res; 2005 Nov; 68(2):96-108. PubMed ID: 16157392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles of chemokines and chemokine receptors in HIV-1 infection.
    Murakami T; Yamamoto N
    Int J Hematol; 2000 Dec; 72(4):412-7. PubMed ID: 11197206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of a CCR5 inhibitor on viral loads in macaques dual-infected with R5 and X4 primate immunodeficiency viruses.
    Wolinsky SM; Veazey RS; Kunstman KJ; Klasse PJ; Dufour J; Marozsan AJ; Springer MS; Moore JP
    Virology; 2004 Oct; 328(1):19-29. PubMed ID: 15380354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemokine (C-C motif) receptor 5-using envelopes predominate in dual/mixed-tropic HIV from the plasma of drug-naive individuals.
    Irlbeck DM; Amrine-Madsen H; Kitrinos KM; Labranche CC; Demarest JF
    AIDS; 2008 Jul; 22(12):1425-31. PubMed ID: 18614865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative evaluation of HIV and SIV co-receptor use with GHOST(3) cell assay.
    Vödrös D; Fenyö EM
    Methods Mol Biol; 2005; 304():333-42. PubMed ID: 16061987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A simian immunodeficiency virus V3 loop mutant that does not efficiently use CCR5 or common alternative coreceptors is moderately attenuated in vivo.
    Pöhlmann S; Münch J; Aziz S; Reeves JD; Otto C; Leslie GJ; Hofmann H; Puffer BA; Baribaud F; Marzi A; Gramberg T; Chen Z; Stolte N; Haaft PT; Heeney JL; Stahl-Hennig C; Mätz-Rensing K; Schneider T; Doms RW; Kirchhoff F
    Virology; 2007 Apr; 360(2):275-85. PubMed ID: 17126374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Viral evolution in macaques coinfected with CCR5- and CXCR4-tropic SHIVs in the presence or absence of vaccine-elicited anti-CCR5 SHIV neutralizing antibodies.
    Burke B; Derby NR; Kraft Z; Saunders CJ; Dai C; Llewellyn N; Zharkikh I; Vojtech L; Zhu T; Srivastava IK; Barnett SW; Stamatatos L
    Virology; 2006 Nov; 355(2):138-51. PubMed ID: 16920175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.